Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-04 Sale | 2025-02-05 4:02 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 23,790 | $3.283 | $78,103 | 1,481,003 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:54 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 10,164 | $2.3125 | $23,504 | 1,999,893 (Direct) | View |
| 2021-02-09 Sale | 2021-02-10 5:06 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 20,000 | $5 | $100,000 | 1,307,457 (Direct) | View |
| 2020-12-14 Sale | 2020-12-16 4:33 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 40,000 | $5.0008 | $200,032 | 1,327,457 (Direct) | View |
| 2020-07-23 Sale | 2020-07-27 5:27 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 20,000 | $5.01 | $100,200 | 1,367,457 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-14 Option Award | 2025-02-19 6:25 pm | N/A 2035-02-14 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 895,800 | $0 | 2,376,803 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:54 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 618,900 | $0 | 1,999,893 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:12 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 418,400 | $0 | 1,725,857 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:53 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 325,850 | $2.81 | 325,850 (Direct) | View |
| 2021-02-13 Option Award | 2021-02-17 4:55 pm | N/A 2031-02-13 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer | 249,000 | $0 | 249,000 (Direct) | View |